CagriSema (Cagrilintide/Semaglutide)

Description

CagriSema is an investigational once-weekly injectable medication being studied for weight loss in adults with obesity or overweight, including some people with type 2 diabetes. It combines cagrilintide, which acts like the natural hormone amylin to control hunger, and semaglutide, a GLP-1 agonist. Taking this medication may help promote satiety, slow stomach emptying, and improve blood sugar control. CagriSema has not yet been approved by the FDA, Health Canada, or other regulators, so current information may change if an official approval and label are released.

Directions

CagriSema is still being studied and does not have an approved dosing schedule. It should only be used in an approved clinical trial or exactly as directed by a healthcare provider. In phase 3 studies, CagriSema was taken as a once-weekly injection under the skin, usually in the stomach area, thigh, or upper arm. The dose was started low and slowly increased over several weeks to help the body adjust and reduce side effects like nausea.

If a dose is missed, it may be taken as soon as possible within a set number of days. Otherwise, skip it. Do not take two doses at once to make up for a missed dose. CagriSema is meant to be used with a lower-calorie diet and increased physical activity.

Ingredients

The active ingredients are cagrilintide and semaglutide.

Cautions

Before using this medication, you may want to consult a healthcare provider about the following:

• Any existing health conditions
• Any allergies
• A list of all medications currently being taken

CagriSema is an investigational medicine that should only be used under medical supervision, and its long-term safety is not yet fully known.

Semaglutide has been linked to thyroid tumors, including medullary thyroid carcinoma, in animal studies. It is not known whether this happens in people.

Stomach-related side effects such as nausea, vomiting, and diarrhea may be common, particularly when starting or increasing the dose. Severe or lasting vomiting or diarrhea can lead to dehydration, which may affect the kidneys.

Inflammation of the pancreas, also called pancreatitis, and gallbladder problems have been linked to GLP-1 receptor agonists like semaglutide. Seek medical care for severe, ongoing stomach pain that may spread to the back, fever, or yellowing of the skin or eyes.

When used in people with type 2 diabetes alongside insulin or medicines that increase insulin release, such as sulfonylureas, there may be a higher risk of low blood sugar, also called hypoglycemia. The dose of those other medicines may need to be lowered.

If you have a history of diabetic eye disease, also called diabetic retinopathy, your healthcare provider may monitor your eyes, as rapid changes in blood sugar can affect this condition.

Because CagriSema slows stomach emptying, it can affect how food and other oral medications are absorbed. Tell your healthcare providers, including any surgeon or anesthesiologist, that you use it before a planned surgery or procedure.

Because semaglutide stays in the body for a long time, it should be stopped well before a planned pregnancy.

Contraindications

CagriSema does not currently have an approved drug label with contraindications. However, based on its ingredients and the eligibility rules used in clinical studies, it should be avoided if any of the following apply:

• A known serious allergic, or hypersensitivity, reaction to cagrilintide, semaglutide, or any of the ingredients.
• A personal or family history of medullary thyroid carcinoma, or MTC, or Multiple Endocrine Neoplasia syndrome type 2, or MEN 2.
• Pregnancy or breastfeeding, as CagriSema has not been studied in these groups.

Side Effects

The most common side effects of CagriSema reported in clinical trials were gastrointestinal. They were usually mild to moderate, tended to occur when starting treatment or raising the dose, and were temporary. They include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal, or stomach, pain
• Decreased appetite

More serious effects are possible. Get medical help for signs of a serious allergic reaction, such as trouble breathing, a severe rash, or swelling of the face, lips, tongue, or throat. Report any severe or lasting stomach pain that may spread to the back, symptoms of gallbladder problems, or signs of low blood sugar, such as shakiness, sweating, confusion, or a fast heartbeat. You should also seek medical advice for any severe or persistent vomiting, diarrhea, any new lump or swelling in the neck, hoarseness, or trouble swallowing.

About Dr. Gerardo Sison (Page Author)

Dr. Sison graduated with honors from the University of Florida. He began his career in pharmacy counseling patients in a community setting and later served in hospitals and clinics. He has also worked in medication therapy management services. Read More....

Product Code : 14029